Nivea Says Leukemia Is in Remission

Singer Nivea said her chronic myeloid leukemia is in remission, sharing the update during an October 7 appearance on The Tamron Hall Show. The singer expressed gratitude, while describing continued treatment and symptoms. Her statement was reported from the interview; the accounts reviewed did not include separate clinical confirmation of her remission status. Nivea said she is participating in a clinical trial for chronic myeloid leukemia, or CML, and takes two targeted medications daily. She described fatigue and bleeding among the symptoms she has experienced and said she has fibroids. Her oncologist, Dr. Colin Vale, appeared with her on the program. The interview reports did not detail what treatment or monitoring she will need going forward. The remission announcement follows Nivea’s public disclosure of her leukemia diagnosis in July 2026. In discussing her progress on the program, she said she had been surprised by how quickly her health had changed and expressed gratitude for the treatment’s effects. Remission does not necessarily mean CML has been cured, and the reports said treatment and monitoring may continue.